Health Care [ 2/12 ] | Biotechnology [ 19/74 ]
NASDAQ | Common Stock
As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private.
KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets.
It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program.
KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016.
KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 30, 26 | -0.43 Increased by +56.57% | -0.38 Decreased by -14.27% |
| Mar 25, 26 | 0.94 Increased by +202.17% | -0.53 Increased by +277.36% |
| Dec 11, 25 | -0.92 Decreased by -1.10% | -0.91 Decreased by -1.10% |
| Sep 3, 25 | -1.12 Decreased by -28.74% | -0.90 Decreased by -24.44% |
| Jul 10, 25 | -0.99 Increased by +2.94% | -0.81 Decreased by -22.22% |
| Mar 12, 25 | -0.92 Decreased by -9.52% | -0.87 Decreased by -5.75% |
| Dec 4, 24 | -0.91 Decreased by -13.75% | -0.91 |
| Sep 5, 24 | -0.87 Decreased by -17.57% | -0.94 Increased by +7.45% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Apr 30, 26 | 59.92 M Increased by +N/A% | -5.37 M Increased by +89.71% | Decreased by -8.96% Decreased by N/A% |
| Jan 31, 26 | 40.86 M Increased by +N/A% | -23.49 M Increased by +51.58% | Decreased by -57.48% Decreased by N/A% |
| Oct 31, 25 | 40.86 M Increased by +N/A% | -23.49 M Increased by +44.43% | Decreased by -57.48% Decreased by N/A% |
| Jul 31, 25 | 1.43 M Increased by +N/A% | -60.10 M Decreased by -48.59% | Decreased by -4.21 K% Decreased by N/A% |
| Apr 30, 25 | 0.00 Decreased by -100.00% | -52.23 M Decreased by -16.97% | Decreased by N/A% Decreased by N/A% |
| Jan 31, 25 | 0.00 Decreased by N/A% | -48.51 M Decreased by -67.11% | Decreased by N/A% Decreased by N/A% |
| Oct 31, 24 | 0.00 Decreased by N/A% | -42.27 M Decreased by -52.87% | Decreased by N/A% Decreased by N/A% |
| Jul 31, 24 | 0.00 Decreased by N/A% | -40.44 M Decreased by -59.75% | Decreased by N/A% Decreased by N/A% |